POSTER: MM-246 Isatuximab (isa) in Relapsed Multiple Myeloma (MM) Patients (pts) with Ultra-High-Risk (UHR) Cytogenetics: ICARIA-MM and IKEMA Subgroup Analysis
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
MM,isatuximab,ultra-high-risk multiple myeloma,extended risk multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要